Tearsheet

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -27%

Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -38%

Attractive yield
FCF Yield is 7.3%

Low stock price volatility
Vol 12M is 39%

Megatrend and thematic drivers
Megatrends include Pet Economy & Humanization. Themes include Pet Insurance & Healthcare Financing, and Pet Health Data Analytics.

Weak multi-year price returns
2Y Excs Rtn is -54%, 3Y Excs Rtn is -70%

Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 25x, P/EPrice/Earnings or Price/(Net Income) is 40x

Key risks
TRUP key risks include [1] margin compression due to a significant lag in its ability to price for veterinary inflation, Show more.

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -27%
1 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -38%
2 Attractive yield
FCF Yield is 7.3%
3 Low stock price volatility
Vol 12M is 39%
4 Megatrend and thematic drivers
Megatrends include Pet Economy & Humanization. Themes include Pet Insurance & Healthcare Financing, and Pet Health Data Analytics.
5 Weak multi-year price returns
2Y Excs Rtn is -54%, 3Y Excs Rtn is -70%
6 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 25x, P/EPrice/Earnings or Price/(Net Income) is 40x
7 Key risks
TRUP key risks include [1] margin compression due to a significant lag in its ability to price for veterinary inflation, Show more.

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 6/12/2026

Trupanion (TRUP) stock has lost about 10% since 2/28/2026 because of the following key factors:

1. Overall Enrolled Pet Decline and Slowing Customer Growth.

Trupanion reported a 2% year-over-year decrease in total enrolled pets, including those from other business segments, to 1,637,665 at the end of fiscal Q1 2026 (March 31, 2026). This indicates challenges in expanding their overall customer base beyond their core subscription offering, despite a 5% increase in subscription enrolled pets during the same period.

2. Decreased Operating and Free Cash Flow.

The company experienced a decline in its cash flow metrics during fiscal Q1 2026. Operating cash flow fell to $14.6 million from $16.0 million in fiscal Q1 2025, while free cash flow decreased to $13.7 million from $14.0 million in fiscal Q1 2025.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The -10.9% change in TRUP stock from 2/28/2026 to 6/13/2026 was primarily driven by a -32.5% change in the company's P/E Multiple.
(LTM values as of)22820266132026Change
Stock Price ($)26.5423.65-10.9%
Change Contribution By: 
Total Revenues ($ Mil)1,4391,4812.9%
Net Income Margin (%)1.4%1.7%29.0%
P/E Multiple59.139.9-32.5%
Shares Outstanding (Mil)4344-0.5%
Cumulative Contribution-10.9%

LTM = Last Twelve Months as of date shown

Market Drivers

2/28/2026 to 6/13/2026
ReturnCorrelation
TRUP-10.9% 
Market (SPY)8.4%1.1%
Sector (XLF)4.2%28.1%

Fundamental Drivers

The -33.0% change in TRUP stock from 11/30/2025 to 6/13/2026 was primarily driven by a -59.4% change in the company's P/E Multiple.
(LTM values as of)113020256132026Change
Stock Price ($)35.2923.65-33.0%
Change Contribution By: 
Total Revenues ($ Mil)1,4001,4815.8%
Net Income Margin (%)1.1%1.7%57.7%
P/E Multiple98.339.9-59.4%
Shares Outstanding (Mil)4344-1.0%
Cumulative Contribution-33.0%

LTM = Last Twelve Months as of date shown

Market Drivers

11/30/2025 to 6/13/2026
ReturnCorrelation
TRUP-33.0% 
Market (SPY)9.2%3.4%
Sector (XLF)0.9%28.5%

Fundamental Drivers

The -49.9% change in TRUP stock from 5/31/2025 to 6/13/2026 was primarily driven by a -54.5% change in the company's P/S Multiple.
(LTM values as of)53120256132026Change
Stock Price ($)47.1923.65-49.9%
Change Contribution By: 
Total Revenues ($ Mil)1,3221,48112.1%
P/S Multiple1.50.7-54.5%
Shares Outstanding (Mil)4344-1.7%
Cumulative Contribution-49.9%

LTM = Last Twelve Months as of date shown

Market Drivers

5/31/2025 to 6/13/2026
ReturnCorrelation
TRUP-49.9% 
Market (SPY)27.3%13.3%
Sector (XLF)6.3%29.9%

Fundamental Drivers

The 5.3% change in TRUP stock from 5/31/2023 to 6/13/2026 was primarily driven by a 55.0% change in the company's Total Revenues ($ Mil).
(LTM values as of)53120236132026Change
Stock Price ($)22.4723.655.3%
Change Contribution By: 
Total Revenues ($ Mil)9561,48155.0%
P/S Multiple1.00.7-28.2%
Shares Outstanding (Mil)4144-5.5%
Cumulative Contribution5.3%

LTM = Last Twelve Months as of date shown

Market Drivers

5/31/2023 to 6/13/2026
ReturnCorrelation
TRUP5.3% 
Market (SPY)84.5%29.2%
Sector (XLF)76.3%32.7%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
TRUP Return10%-64%-36%58%-22%-38%-81%
Peers Return-11%-47%-3%30%22%-23%-44%
S&P 500 Return27%-19%24%23%16%8%97%

Monthly Win Rates [3]
TRUP Win Rate50%33%42%42%33%17% 
Peers Win Rate50%35%45%45%45%30% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
TRUP Max Drawdown-42%-67%-71%-44%-40%-43% 
Peers Max Drawdown-42%-57%-50%-36%-34%-39% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: LMND, CHWY, WOOF, ZTS, IDXX. See TRUP Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/12/2026 (YTD)

How Low Can It Go

EventTRUPS&P 500
2025 US Tariff Shock
  % Loss-31.8%-18.8%
  % Gain to Breakeven46.6%23.1%
  Time to Breakeven85 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-28.2%-9.5%
  % Gain to Breakeven39.3%10.5%
  Time to Breakeven30 days24 days
2020 COVID-19 Crash
  % Loss-28.3%-33.7%
  % Gain to Breakeven39.5%50.9%
  Time to Breakeven39 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-30.3%-19.2%
  % Gain to Breakeven43.4%23.8%
  Time to Breakeven95 days105 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-17.5%-3.7%
  % Gain to Breakeven21.3%3.9%
  Time to Breakeven29 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-23.9%-12.2%
  % Gain to Breakeven31.4%13.9%
  Time to Breakeven34 days62 days

Compare to LMND, CHWY, WOOF, ZTS, IDXX

In The Past

Trupanion's stock fell -31.8% during the 2025 US Tariff Shock. Such a loss loss requires a 46.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventTRUPS&P 500
2025 US Tariff Shock
  % Loss-31.8%-18.8%
  % Gain to Breakeven46.6%23.1%
  Time to Breakeven85 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-28.2%-9.5%
  % Gain to Breakeven39.3%10.5%
  Time to Breakeven30 days24 days
2020 COVID-19 Crash
  % Loss-28.3%-33.7%
  % Gain to Breakeven39.5%50.9%
  Time to Breakeven39 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-30.3%-19.2%
  % Gain to Breakeven43.4%23.8%
  Time to Breakeven95 days105 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-23.9%-12.2%
  % Gain to Breakeven31.4%13.9%
  Time to Breakeven34 days62 days
2014-2016 Oil Price Collapse
  % Loss-40.2%-6.8%
  % Gain to Breakeven67.3%7.3%
  Time to Breakeven371 days15 days

Compare to LMND, CHWY, WOOF, ZTS, IDXX

In The Past

Trupanion's stock fell -31.8% during the 2025 US Tariff Shock. Such a loss loss requires a 46.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Trupanion (TRUP)

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

AI Analysis | Feedback

Here are 1-3 brief analogies for Trupanion:

  • Blue Cross Blue Shield for pets
  • Lemonade for pets

AI Analysis | Feedback

  • Medical Insurance for Cats and Dogs: This service provides comprehensive medical coverage for unexpected illnesses and injuries for pets on a monthly subscription basis.

AI Analysis | Feedback

Trupanion (TRUP) primarily sells its medical insurance services to individual pet owners on a monthly subscription basis. The company serves the following major categories of customers:

  • Cat Owners: Individuals who own cats and subscribe to Trupanion's medical insurance plans for their feline companions.
  • Dog Owners: Individuals who own dogs and subscribe to Trupanion's medical insurance plans for their canine companions.

AI Analysis | Feedback

  • White Mountains Insurance Group, Ltd. (WTM)
  • Munich Re Group (MURGY)
  • Swiss Re Ltd. (SSREY)

AI Analysis | Feedback

Margi Tooth

President & Chief Executive Officer

Margi Tooth joined Trupanion in 2013 and was appointed Chief Executive Officer in August 2024. She brings nearly two decades of experience in the pet insurance category, including over seven years with the UK's largest pet insurance provider and a stint with the European insurance giant Allianz prior to joining Trupanion. At Trupanion, she previously held leadership positions such as Chief Marketing Officer, Chief Revenue Officer, and President. Under her leadership, Trupanion has achieved significant milestones, including surpassing $1 billion in revenue and reaching over 1 million subscription pets.

Fawwad Qureshi

Chief Financial Officer

Fawwad Qureshi assumed the role of Chief Financial Officer at Trupanion in September 2023. He possesses over 20 years of senior-level financial experience, having successfully driven revenue and profitability growth for publicly traded, global companies. Most recently, he served as Senior Vice President of Finance and CFO of Brands at Expedia Group, where he held full profit and loss (P&L) and commercial responsibility for a portfolio of consumer brands valued over $9 billion, including Expedia, Vrbo, Hotels.com, Orbitz, and Travelocity. Before his tenure at Expedia, Qureshi was the CFO for Nike Global Technology and held progressively senior finance positions at Intel.

John Gallagher

Chief Operating Officer

John Gallagher has served as Trupanion's Chief Operating Officer since September 2024. Prior to this role, he held various positions within the company, including Executive Vice President of Global Support Services from April 2023 to September 2024, interim head of Global Support Services from January 2023 to April 2023, and General Manager from January 2022 to January 2023, in addition to other roles within Trupanion's Contact Center.

Brenna McGibney

Chief Admin Officer

Brenna McGibney is Trupanion's Chief Admin Officer, responsible for overseeing global people operations, learning and development, and pricing. She joined the company as Chief People Officer in 2022, bringing with her over 20 years of global HR and operations experience. Before joining Trupanion, McGibney served as the Vice President of Human Resources and Corporate Communications at MCAN Financial Group and as Vice President, Talent and Associate Experience for LoyaltyOne.

Emily Dreyer

Chief Revenue Officer

Emily Dreyer has served as Trupanion's Chief Revenue Officer since June 2025.

AI Analysis | Feedback

The key risks to Trupanion's business are primarily centered around its profitability, the highly competitive pet insurance market, and ongoing regulatory challenges.

  1. Profitability Concerns and High Operating Costs: Trupanion has historically faced significant cumulative net losses and has struggled to achieve consistent GAAP profitability. This is largely driven by persistent veterinary inflation, which escalates the costs of claims and can necessitate price increases, potentially impacting customer retention. Additionally, high pet acquisition costs further pressure the company's margins and overall profitability.

  2. Intense Competition: The pet insurance industry is characterized by strong competition from a variety of providers, including those offering low-cost, narrow coverage plans and others with high-value annual plans. Trupanion must continuously differentiate its offerings and demonstrate value to pet owners in a market that has also seen consolidation among brands, intensifying the competitive landscape.

  3. Regulatory Challenges: Operating in a heavily regulated industry, Trupanion faces the risk of non-compliance with state, federal, and international laws and regulations. The company has previously been cited and fined by state regulators for various violations, including using unlicensed individuals to sell insurance, exceeding limits on gifts for referrals to veterinarians, and charging inconsistent rates to different customers. Maintaining strict regulatory compliance is essential to avoid penalties and safeguard its market reputation.

AI Analysis | Feedback

```html
  • Emergence of Tech-First Insurtech Competitors: Companies like Lemonade, with their AI-driven, digital-first platforms, are fundamentally changing the delivery of insurance services. These insurtechs leverage advanced machine learning for underwriting, claims processing, and customer service, offering a highly streamlined, often immediate, and personalized experience. This model directly challenges traditional insurance providers like Trupanion by offering a more efficient, user-friendly, and potentially lower-cost alternative that appeals to a tech-savvy consumer base, similar to how Netflix disrupted Blockbuster's physical rental model.
  • Vertical Integration and Consolidation by Large Veterinary Corporate Groups: Major players in the veterinary industry, such as Mars Veterinary Health (owners of Banfield, VCA) and JAB Holdings (owners of NVA, PetVet Care Centers, and Figo Pet Insurance), are consolidating veterinary practices and increasingly integrating pet insurance offerings. By owning large networks of clinics and simultaneously offering their own insurance products, these groups can create highly integrated pet care ecosystems. This allows them to offer "in-house" insurance directly at the point of care, leveraging their vast customer base and potentially cutting out third-party insurers like Trupanion, much like how Uber challenged traditional taxi dispatch services by integrating technology with service delivery.
```

AI Analysis | Feedback

The addressable markets for Trupanion's main products and services, which include medical insurance for cats and dogs, are identified for the United States, Canada, and Australia as follows:

  • United States: The U.S. pet insurance market was valued at approximately USD 5.34 billion in 2024. This market is projected to expand significantly, reaching an estimated USD 20.05 billion by 2032.
  • Canada: The Canadian pet insurance market generated revenues of approximately USD 453.2 million in 2024. Projections indicate growth to about USD 1,526.4 million by 2033.
  • Australia: The Australian pet insurance market recorded revenues of approximately USD 1,088.6 million in 2024. This market is anticipated to grow to an estimated USD 5,227.0 million by 2033.
  • Puerto Rico: Specific addressable market size data for pet insurance in Puerto Rico was not readily available from the conducted searches.

AI Analysis | Feedback

Trupanion (TRUP) is expected to drive future revenue growth over the next 2-3 years through several key initiatives:

  1. Pricing Adjustments: Trupanion anticipates that pricing will continue to be a primary contributor to revenue growth, building on its successful alignment of pricing with rising veterinary costs in 2025. While its contribution may gradually shift, pricing is still expected to lead revenue growth in 2026.
  2. Increased Pet Acquisition (Customer Growth): The company is focused on accelerating pet-count growth by increasing new pet acquisitions. Trupanion plans to expand its presence within the veterinary channel and enhance pet acquisition spending to reach pet owners earlier in their purchasing journey.
  3. Expansion of Product Offerings, including Lower-Priced Options: Trupanion is exploring and developing new product offerings, including lower-priced insurance plans, to cater to a broader market and address pet owners' budget constraints. Additionally, the company is developing "Landspath," a new vet-distributed product with unique economics, which is expected to rival or surpass the pet insurance business itself and represents a new strategic initiative.
  4. Technological Investments and Operational Efficiency: Continued investment in technology, such as claims automation and artificial intelligence, is aimed at improving operational efficiencies and enhancing the member experience. These advancements are expected to contribute to adjusted operating margin expansion, supporting sustainable growth.
  5. Market Penetration and International Expansion: Trupanion aims to increase its market penetration within existing operating geographies (United States, Canada, Puerto Rico, and Australia) and strategically enter new international markets. The company sees significant growth opportunities in these underpenetrated markets.

AI Analysis | Feedback

Share Repurchases

  • A $50 million share buyback program was authorized by Trupanion's board on February 12, 2026.
  • A previous buyback program, announced on April 30, 2021, saw the repurchase of 95,021 shares for $5.75 million, completed by December 31, 2025.

Share Issuance

  • Trupanion completed a Private Investment in Public Equity (PIPE) funding round in October 2020, raising $200 million.

Inbound Investments

  • Aflac Incorporated made a $200 million investment in Trupanion, confirming a strategic alliance in North America, as announced in December 2023.

Outbound Investments

  • Trupanion acquired Smart Paws GmbH, a pet insurance provider operating in Germany and Switzerland, on August 31, 2022.
  • In 2022, Trupanion completed three acquisitions across Germany, the Czech Republic, and Slovakia, including PetExpert and Royal Blue.

Capital Expenditures

  • Capital expenditures in the last 12 months were -$14.13 million.
  • Trupanion projects capital expenditures of $23 million for 2026, $25 million for 2027, and $27 million for 2028.
  • Capital allocation for the upcoming year will focus on pet acquisition costs, the LabSpec pet food business, and technology investments.

Better Bets vs. Trupanion (TRUP)

Latest Trefis Analyses

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

TRUPLMNDCHWYWOOFZTSIDXXMedian
NameTrupanionLemonade Chewy Petco He.Zoetis IDEXX La. 
Mkt Price23.6557.4919.312.7579.57560.8840.57
Mkt Cap1.04.48.00.833.644.76.2
Rev LTM1,48184512,8435,9659,5094,4465,205
Op Inc LTM109-3061293,5731,406306
FCF LTM75205841622,2371,068373
FCF 3Y Avg47-43434612,056901247
CFO LTM88307142992,7901,210506
CFO 3Y Avg59-345782132,6871,033395

Growth & Margins

TRUPLMNDCHWYWOOFZTSIDXXMedian
NameTrupanionLemonade Chewy Petco He.Zoetis IDEXX La. 
Rev Chg LTM12.1%51.2%6.1%-1.9%2.6%13.1%9.1%
Rev Chg 3Y Avg15.8%40.6%7.0%-0.8%5.5%9.1%8.0%
Rev Chg Q12.3%70.6%7.7%0.2%2.9%14.3%10.0%
QoQ Delta Rev Chg LTM2.9%14.5%1.9%0.1%0.7%3.3%2.4%
Op Inc Chg LTM43.3%-144.9%220.2%5.0%22.7%43.3%
Op Inc Chg 3Y Avg51.5%-246.3%685.1%7.6%15.1%51.5%
Op Mgn LTM7.3%-2.4%2.2%37.6%31.6%7.3%
Op Mgn 3Y Avg5.8%-1.2%0.9%36.8%30.2%5.8%
QoQ Delta Op Mgn LTM0.3%-0.4%0.1%-0.1%0.0%0.1%
CFO/Rev LTM5.9%3.6%5.6%5.0%29.3%27.2%5.8%
CFO/Rev 3Y Avg4.3%-8.1%4.8%3.5%29.3%25.5%4.5%
FCF/Rev LTM5.1%2.3%4.6%2.7%23.5%24.0%4.8%
FCF/Rev 3Y Avg3.4%-9.7%3.5%1.0%22.4%22.2%3.5%

Valuation

TRUPLMNDCHWYWOOFZTSIDXXMedian
NameTrupanionLemonade Chewy Petco He.Zoetis IDEXX La. 
Mkt Cap1.04.48.00.833.644.76.2
P/S0.75.20.60.13.510.02.1
P/Op Inc9.5-26.16.19.431.89.5
P/EBIT24.6-24.96.49.531.724.6
P/E39.9-31.631.3139.812.740.835.6
P/CFO11.7145.711.22.612.036.911.9
Total Yield2.5%-3.2%3.2%0.7%10.5%2.5%2.5%
Dividend Yield0.0%0.0%0.0%0.0%2.6%0.0%0.0%
FCF Yield 3Y Avg3.7%-3.6%4.1%7.2%3.2%2.2%3.5%
D/E0.10.00.13.60.30.00.1
Net D/E-0.3-0.1-0.03.40.20.00.0

Returns

TRUPLMNDCHWYWOOFZTSIDXXMedian
NameTrupanionLemonade Chewy Petco He.Zoetis IDEXX La. 
1M Rtn5.8%6.9%-10.1%6.2%5.4%5.3%5.6%
3M Rtn-4.4%4.2%-24.2%-24.0%-30.9%-2.3%-14.2%
6M Rtn-34.9%-26.2%-41.0%-10.4%-32.4%-20.4%-29.3%
12M Rtn-53.5%42.1%-53.7%11.3%-50.8%7.3%-21.8%
3Y Rtn-5.4%185.0%-51.4%-67.9%-50.2%20.1%-27.8%
1M Excs Rtn4.9%8.9%-10.6%7.6%7.2%6.3%6.7%
3M Excs Rtn-16.5%-7.8%-36.2%-36.1%-42.9%-14.3%-26.3%
6M Excs Rtn-44.0%-34.6%-53.3%-20.3%-39.9%-28.0%-37.2%
12M Excs Rtn-77.7%12.1%-76.0%-18.8%-74.8%-16.4%-46.8%
3Y Excs Rtn-70.0%124.8%-121.6%-142.0%-123.7%-49.7%-95.8%

Comparison Analyses

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Subscription business989857713597495
Other Business450429396309204
Total1,4391,2861,109905699


Operating Income by Segment
$ Mil20252024202320222021
Subscription business22-1-36-40-34
Gain (loss) from investment in joint venture-0-0-0-0-0
Other Business-8-8-4-3-1
Total14-10-41-43-35


Price Behavior

Price Behavior
Market Price$23.65 
Market Cap ($ Bil)1.0 
First Trading Date07/18/2014 
Distance from 52W High-58.1% 
   50 Days200 Days
DMA Price$24.32$33.20
DMA Trenddowndown
Distance from DMA-2.7%-28.8%
 3M1YR
Volatility43.2%39.0%
Downside Capture36.8294.91
Upside Capture6.16-22.22
Correlation (SPY)-3.4%11.4%
TRUP Betas & Captures as of 5/31/2026

 1M2M3M6M1Y3Y
Beta-2.010.310.240.280.541.29
Up Beta-2.240.21-0.150.040.661.40
Down Beta0.841.360.480.550.621.21
Up Capture-198%-37%-11%-26%-8%131%
Bmk +ve Days13283667141432
Stock +ve Days6182955111360
Down Capture-317%164%96%102%109%109%
Bmk -ve Days7132757109318
Stock -ve Days14233469138385

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TRUP
TRUP-54.3%39.0%-1.93-
Sector ETF (XLF)6.2%14.7%0.2029.8%
Equity (SPY)24.9%12.3%1.5211.9%
Gold (GLD)25.5%27.4%0.81-15.0%
Commodities (DBC)30.1%19.0%1.25-5.3%
Real Estate (VNQ)13.5%13.5%0.695.2%
Bitcoin (BTCUSD)-41.7%42.2%-1.165.3%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TRUP
TRUP-23.9%71.4%-0.07-
Sector ETF (XLF)8.8%18.6%0.3536.0%
Equity (SPY)13.5%17.1%0.6141.6%
Gold (GLD)16.8%18.2%0.752.5%
Commodities (DBC)8.4%19.4%0.334.1%
Real Estate (VNQ)2.8%18.8%0.0537.6%
Bitcoin (BTCUSD)13.6%54.4%0.4419.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with TRUP
TRUP5.6%62.3%0.36-
Sector ETF (XLF)12.9%22.2%0.5330.6%
Equity (SPY)15.3%17.9%0.7338.3%
Gold (GLD)12.5%16.1%0.644.5%
Commodities (DBC)6.7%18.0%0.297.1%
Real Estate (VNQ)5.7%20.7%0.2430.4%
Bitcoin (BTCUSD)60.3%66.8%1.0011.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date5292026
Short Interest: Shares Quantity3.9 Mil
Short Interest: % Change Since 51520264.2%
Average Daily Volume0.4 Mil
Days-to-Cover Short Interest9.7 days
Basic Shares Quantity43.5 Mil
Short % of Basic Shares8.9%

Earnings Returns History

Updated 6/3/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
4/30/20261.4%6.7%-7.2%
2/12/2026-13.0%-9.6%-21.1%
11/6/2025-8.3%-6.4%-8.7%
2/19/2025-25.5%-28.8%-22.6%
10/30/2024-0.6%-8.9%-3.3%
8/8/20249.3%23.6%22.4%
5/2/2024-16.5%4.6%18.2%
2/15/2024-35.1%-34.8%-23.7%
...
SUMMARY STATS   
# Positive799
# Negative151313
Median Positive9.3%13.3%18.8%
Median Negative-11.3%-9.6%-12.1%
Max Positive22.7%25.8%40.7%
Max Negative-35.1%-38.0%-39.2%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202604/30/202610-Q
12/31/202502/13/202610-K
09/30/202511/06/202510-Q
06/30/202508/07/202510-Q
03/31/202505/01/202510-Q
12/31/202402/27/202510-K
09/30/202411/01/202410-Q
06/30/202408/09/202410-Q
03/31/202405/03/202410-Q
12/31/202302/27/202410-K
09/30/202311/03/202310-Q
06/30/202308/04/202310-Q
03/31/202305/05/202310-Q
12/31/202202/16/202310-K
09/30/202211/04/202210-Q
06/30/202208/04/202210-Q

Insider Activity

Updated 6/9/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Weinrauch, SteveEVP, North Am & Vet StrategyDirectSell609202622.006,674146,8281,717,364Form
2Gallagher, John RChief Operating OfficerDirectSell601202621.693,60378,153717,220Form
3Qureshi, FawwadChief Financial OfficerDirectSell527202622.186,177137,01646,160Form
4Tooth, MargaretCEODirectSell527202621.8649110,7333,855,645Form
5Gallagher, John RChief Operating OfficerDirectSell429202627.4743111,840866,019Form
Core Cache Last Updated: 6/13/2026